Skip to main navigation Skip to search Skip to main content

A Novel Dual-Function Redox Modulator Relieves Oxidative Stress and Anti-Angiogenic Response in Placental Villus Explant Exposed to Hypoxia—Relevance for Preeclampsia Therapy

  • Diana Pintye
  • , Réka E. Sziva
  • , Maxim Mastyugin
  • , Brett C. Young
  • , Sonako Jacas
  • , Marianna Török
  • , Saira Salahuddin
  • , Prakash Jagtap
  • , Garry J. Southan
  • , Zsuzsanna K. Zsengellér
  • Harvard University
  • Semmelweis University
  • University of Massachusetts Boston
  • Akkadian Therapeutics

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Preeclampsia (PE) is a severe, life-threatening complication during pregnancy (~5–7%), and no causative treatment is available. Early aberrant spiral artery remodeling is associated with placental stress and the release of oxygen radicals and other reactive oxygen species (ROS) in the placenta. This precedes the production of anti-angiogenic factors, which ultimately leads to endothelial and trophoblast damage and the key features of PE. We tested whether a novel dual-function redox modulator—AKT-1005—can effectively reduce placental oxidative stress and alleviate PE symptoms in vitro. Method: Isolated human villous explants were exposed to hypoxia and assessed to determine whether improving cell-redox function with AKT-1005 diminished ROS production, mitochondrial stress, production of the transcription factor HIF1A, and downstream anti-angiogenic responses (i.e., sFLT1, sEng production). MitoTEMPO was used as a reference antioxidant. Results: In our villous explant assays, pretreatment with AKT-1005 reduced mitochondrial-derived ROS production, reduced HIF-1A, sFLT1, and sEng protein expression, while increasing VEGF in hypoxia-exposed villous trophoblast cells, with better efficiency than MitoTEMPO. In addition, AKT-1005 improved mitochondrial electron chain enzyme activity in the stressed explant culture. Conclusions: The redox modulator AKT-1005 has the potential to intervene with oxidative stress and can be efficacious for PE therapy. Future studies are underway to assess the in vivo efficacy of HMP.

Original languageEnglish
Article number1229
JournalBiology
Volume12
Issue number9
DOIs
StatePublished - Sep 2023

ASJC Scopus Subject Areas

  • General Biochemistry,Genetics and Molecular Biology
  • General Immunology and Microbiology
  • General Agricultural and Biological Sciences

Keywords

  • hypoxia
  • nitric oxide-donor
  • placental villous explant
  • preeclampsia
  • redox modulator
  • SOD mimetic

Fingerprint

Dive into the research topics of 'A Novel Dual-Function Redox Modulator Relieves Oxidative Stress and Anti-Angiogenic Response in Placental Villus Explant Exposed to Hypoxia—Relevance for Preeclampsia Therapy'. Together they form a unique fingerprint.

Cite this